person

Yannick G.

Country
France
Department
Pôle Urgence Pasteur

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 23 partner sites.

Specializations

Oncology – Solid Tumors

Research focuses on advanced malignant neoplasms of the gastrointestinal tract, prostate, lung, pancreas and head‑and‑neck regions.

  • unresectable metastatic colorectal cancer
  • metastatic hormone‑naïve prostate cancer
  • BRAFV600E‑mutant non‑small cell lung cancer
  • pancreatic adenocarcinoma
  • head and neck squamous cell carcinoma

The investigator contributes to therapeutic strategies that integrate targeted agents, immunotherapies and novel combination regimens.

Hematology – Acute Leukemia and Lymphoma

Investigations address frontline and salvage therapies for adult acute lymphoblastic leukemia, acute myeloid leukemia and primary central nervous system lymphoma.

  • younger adult acute lymphoblastic leukemia
  • adult acute myeloid leukemia
  • primary central nervous system lymphoma
  • blinatumomab‑based frontline regimens
  • isotuximab integration in T‑ALL

Efforts aim to improve survival through immunotherapy, molecularly guided transplantation and optimized chemotherapy dosing.

Neurology – Neurodegenerative and Demyelinating Disorders

Studies target cognitive and psychiatric manifestations of neurodegeneration and inflammatory demyelination.

  • Alzheimer’s disease psychosis
  • adult brainstem glioma progression
  • relapsing multiple sclerosis
  • ischemic stroke outcomes
  • neurocognitive effects of ADHD therapies

Therapeutic exploration includes monoclonal antibodies, disease‑modifying agents and neuroprotective strategies.

Cardiovascular and Renal Medicine

Clinical work includes acute myocardial infarction, chronic heart failure, stroke and advanced chronic kidney disease with cardiovascular risk.

  • acute myocardial infarction management
  • chronic heart failure optimization
  • low‑dose rivaroxaban in chronic kidney disease
  • cardiovascular outcome improvement in dialysis patients
  • stroke reperfusion strategies

Research evaluates anticoagulation, novel lipid‑lowering agents and integrated heart‑kidney care pathways.

Gastrointestinal & Immune‑Mediated Inflammatory Diseases

Focus is on inflammatory bowel disease, rheumatoid arthritis and related systemic inflammatory conditions.

  • Crohn’s disease biologic sequencing
  • ulcerative colitis maintenance therapy
  • rheumatoid arthritis rituximab optimization
  • polymyalgia rheumatica glucocorticoid tapering
  • immune thrombocytopenia treatment strategies

The investigator assesses combination regimens, dose‑adjusted biologics and real‑world effectiveness.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.